The Purine Biosynthesis Repressor, PurR, Contributes to Vancomycin Susceptibility of Methicillin-resistant Staphylococcus aureus in Experimental Endocarditis.

Saved in:
Bibliographic Details
Title: The Purine Biosynthesis Repressor, PurR, Contributes to Vancomycin Susceptibility of Methicillin-resistant Staphylococcus aureus in Experimental Endocarditis.
Authors: Xiong YQ; The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.; Department of Medicine, Division of Infectious Diseases, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Li Y; The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA., Goncheva MI; Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada., Elsayed AM; The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA., Zhu F; The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA., Li L; The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA., Abdelhady W; The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA., Flannagan RS; Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada., Yeaman MR; The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.; Department of Medicine, Division of Infectious Diseases, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.; Department of Medicine, Division of Molecular Medicine, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA., Bayer AS; The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.; Department of Medicine, Division of Infectious Diseases, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Heinrichs DE; Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada.
Source: The Journal of infectious diseases [J Infect Dis] 2024 Jun 14; Vol. 229 (6), pp. 1648-1657.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38297970
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The Purine Biosynthesis Repressor, PurR, Contributes to Vancomycin Susceptibility of Methicillin-resistant Staphylococcus aureus in Experimental Endocarditis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Xiong+YQ%22">Xiong YQ</searchLink>; The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.; Department of Medicine, Division of Infectious Diseases, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.<br /><searchLink fieldCode="AU" term="%22Goncheva+MI%22">Goncheva MI</searchLink>; Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Elsayed+AM%22">Elsayed AM</searchLink>; The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.<br /><searchLink fieldCode="AU" term="%22Zhu+F%22">Zhu F</searchLink>; The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.<br /><searchLink fieldCode="AU" term="%22Li+L%22">Li L</searchLink>; The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.<br /><searchLink fieldCode="AU" term="%22Abdelhady+W%22">Abdelhady W</searchLink>; The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.<br /><searchLink fieldCode="AU" term="%22Flannagan+RS%22">Flannagan RS</searchLink>; Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Yeaman+MR%22">Yeaman MR</searchLink>; The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.; Department of Medicine, Division of Infectious Diseases, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.; Department of Medicine, Division of Molecular Medicine, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.<br /><searchLink fieldCode="AU" term="%22Bayer+AS%22">Bayer AS</searchLink>; The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.; Department of Medicine, Division of Infectious Diseases, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Heinrichs+DE%22">Heinrichs DE</searchLink>; Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2024 Jun 14; Vol. 229 (6), pp. 1648-1657.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38297970
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/infdis/jiad577
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1648
    Titles:
      – TitleFull: The Purine Biosynthesis Repressor, PurR, Contributes to Vancomycin Susceptibility of Methicillin-resistant Staphylococcus aureus in Experimental Endocarditis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Xiong YQ
      – PersonEntity:
          Name:
            NameFull: Li Y
      – PersonEntity:
          Name:
            NameFull: Goncheva MI
      – PersonEntity:
          Name:
            NameFull: Elsayed AM
      – PersonEntity:
          Name:
            NameFull: Zhu F
      – PersonEntity:
          Name:
            NameFull: Li L
      – PersonEntity:
          Name:
            NameFull: Abdelhady W
      – PersonEntity:
          Name:
            NameFull: Flannagan RS
      – PersonEntity:
          Name:
            NameFull: Yeaman MR
      – PersonEntity:
          Name:
            NameFull: Bayer AS
      – PersonEntity:
          Name:
            NameFull: Heinrichs DE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 06
              Text: 2024 Jun 14
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6613
          Numbering:
            – Type: volume
              Value: 229
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: The Journal of infectious diseases
              Type: main
ResultId 1